
Equateq and Dignity Sciences Announce IP and Supply Deal
Equateq and Dignity Sciences Ltd today announced a two-tier strategic deal comprising a supply agreement, and the assignment of IP covering the use of synthetic lipids for the topical treatment of hyper-proliferative skin conditions.


